Webinar series: Getting ready for disease-modifying treatments
Join the faculty’s CPD workshops that explore “getting ready to deliver disease-modifying treatments” should they be approved in UK. These workshops build on the findings from our 2021 report Are we ready to deliver disease-modifying treatments? (details of the report are at the bottom of this page)
- 2 November 4-5pm: Spotlight on the future: Watch the video
- 9 November 4-5pm: Alzheimer's Disease and fluid biomarkers: Watch the video
- 23 November 4-5pm: Imaging and safety – focus on ARIA: Watch the video
- 30 November 4-5pm: Insights from neurology services: Watch the video
The webinar workshops will run between 4-5pm with time for questions and discussion. These will be free and delivered remotely via Teams. Please note you have to register for each webinar separately.
Are we ready to deliver disease-modifying treatments?
The report, from Alzheimer’s Research UK and the Royal College of Psychiatrists Are we ready to deliver disease-modifying treatments? finds that specialists are keen to embrace the arrival of new dementia drug treatments, but need much more support in order to effectively implement them into their clinical practices.
The joint research highlights significant gaps in support that old age psychiatrists need to effectively diagnose people with Alzheimer’s Disease before dementia and deliver future treatments to those living with the condition.
Over 500 old age psychiatrists contributed to the report which shows that services are not ready to deliver disease-modifying treatments for Alzheimer's disease, the most common cause of dementia:
- 36% of psychiatrists thought their services could adapt to deliver disease-modifying treatments within a year
- 6% of psychiatry services are able to fully meet the NICE guidelines regarding accessing further biomarker and diagnostic tests for Alzheimer’s disease.
Dr Mani Krishnan, chair of the Old Age Psychiatry Faculty, said:
“Early accurate diagnosis plays a vital role in the treatment of dementia. It’s important that Psychiatrists are given access to the diagnostic tools and the training to help reduce the progression of this debilitating illness by way of diagnosing Alzheimer’s disease even before developing dementia."